Xencor reported $12.37M in Selling and Administration Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.3B 174M
Alnylam Pharmaceuticals ALNY:US USD 235.86M 65.88M
Amgen AMGN:US USD 1.29B 40M
Arrowhead Research ARWR:US USD 32.74M 1.12M
AstraZeneca AZN:LN USD 3.35B 280M
Biogen BIIB:US USD 563.3M 9.3M
Bristol Myers Squibb BMY:US USD 1.93B 147M
Cytokinetics CYTK:US USD 48.22M 5.51M
GlaxoSmithKline GSK:LN GBP 1.97B 13M
Johnson & Johnson JNJ:US USD 6.09B 137M
Karyopharm Therapeutics KPTI:US USD 34.64M 2.69M
Macrogenics MGNX:US USD 15.35M 1.69M
Merk MRK:US USD 2.47B 13M
Novartis NOVN:VX USD 3.4B 185M
Pfizer PFE:US USD 3.54B 345M
Regeneron Pharmaceuticals REGN:US USD 529.1M 52.8M
Seattle Genetics SGEN:US USD 210.38M 9.88M
Xencor XNCR:US USD 12.37M 1.28M